ORCID Profile
0000-0001-5134-7408
Current Organisations
James Cook University
,
University of Hartford Department of Health Sciences and Nursing
,
University of Sydney School of Public Health
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Springer Science and Business Media LLC
Date: 09-03-2011
Publisher: Public Library of Science (PLoS)
Date: 25-05-2012
Publisher: Oxford University Press (OUP)
Date: 08-01-2013
DOI: 10.1093/CID/CIS1210
Abstract: Mycoplasma genitalium (MG) is an emerging sexually transmitted infection (STI) that is potentially associated with reproductive tract sequelae in women. This study aimed to estimate MG incidence and treatment failure and provide estimates of organism load in infection. 1110 women aged 16-25 years were recruited from primary care clinics in Australia. Women were tested for MG at baseline, 6 months, and 12 months, and MG organism load was measured by quantitative polymerase chain reaction (PCR). MG-positive cases were screened for MG 23S ribosomal RNA (rRNA) gene point mutations shown to confer azithromycin resistance using high-resolution melt following PCR. MG incidence rate was 1.3 per 100 person-years (n=14 95% confidence interval [CI], .8-2.3) women reporting 3 or more sex partners in the last 12 months had an increased rate of incident infection (rate ratio [RR], 5.1 95% CI, 1.3-19.6]). There were 3 cases of MG reinfection (0.8 per 100 person-years [95% CI, .1-.9]. Organism load was higher for prevalent than incident infection (P=.04). There were 3 cases of treatment failure (9.4% [95% CI, 2.0-25.0]) organism load was higher in cases with treatment failure than in successfully treated cases (P<.01). An MG 23S rRNA mutation was detected in 5 cases (3 cases of treatment failure and 2 successfully treated). Although MG incidence was relatively low, testing should be recommended for women considered to be at increased risk based on sexual history. Our results also suggest that organism load might be important in azithromycin treatment failure.
Publisher: Informa UK Limited
Date: 19-11-2013
Publisher: Informa UK Limited
Date: 22-12-2015
Publisher: Elsevier BV
Date: 1981
Publisher: Public Library of Science (PLoS)
Date: 05-03-2013
Publisher: Informa UK Limited
Date: 07-2013
Publisher: Springer Science and Business Media LLC
Date: 18-08-2009
Publisher: Springer Science and Business Media LLC
Date: 02-2011
Publisher: CSIRO Publishing
Date: 2013
DOI: 10.1071/SH12019
Abstract: Objective To determine young women’s experience of having a chlamydia (Chlamydia trachomatis) test as part of a chlamydia incidence study, and to determine how women who tested positive during the study experienced having a test compared with the experience of women who always tested negative. Methods: Women in an Australian chlamydia incidence study were tested at 3- to 6-monthly intervals during a 12-month period. At the final stage of the study, the women completed a questionnaire about how they felt about testing positive or how they anticipated they might feel about testing positive if they only tested negative. Questions about future sexual behaviour and testing were included. Results: The questionnaire was completed by 872 out of 1116 (78%) women, including 67 women who tested positive. Many women (75%) felt anxious when having a chlamydia test but women who tested positive were less concerned about their future health (61% v. 81%, P 0.01), were less concerned about their partner’s reactions (62% v. 79%, P 0.01) and were more likely to discuss their diagnosis with other people (57% v. 36%, P 0.01). Conclusions: The participants in the study were pleased to have been tested and supported a screening program. Women who tested positive were less concerned about having a positive result than women who tested negative anticipated they might be. Implications: Clinicians need to be aware that having a chlamydia test can cause anxiety in young women and for a screening program to be successful, this must be addressed.
Publisher: Informa UK Limited
Date: 2008
DOI: 10.1080/01421590801965129
Abstract: Providing undergraduate and post-graduate rural training opportunities aids rural medical recruitment. Medical schools that provide rural educational placements, and the communities that host those placements, must give serious consideration to the structure and supports required to ensure both quality and enjoyment of rural placements. This paper presents tips for success gleaned from the results of experience in providing rural placement opportunities to medical students throughout their medical school experience.
Location: United States of America
Location: United States of America
Location: Australia
Location: Australia
Location: United States of America
Location: United States of America
Location: United States of America
Location: No location found
Location: United States of America
No related grants have been discovered for Hudson Birden.